- Home
- SVRA vs CURV Comparison
SVRA vs CURV Comparison
Compare SVRA & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | CURV |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 185.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SVRA | CURV |
|---|---|---|
| Price | $6.95 | $1.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | ★ $6.88 | $1.59 |
| AVG Volume (30 Days) | ★ 3.0M | 452.9K |
| Earning Date | 11-12-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,039,486,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.89 | $1.03 |
| 52 Week High | $7.00 | $7.19 |
Technical Indicators
Market Signals| Indicator | SVRA | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 81.34 | 37.89 |
| Support Level | $5.55 | $1.08 |
| Resistance Level | $6.78 | $1.17 |
| Average True Range (ATR) | 0.45 | 0.10 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 98.10 | 2.30 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.